ABBIO CO LTD has a total of 12 patent applications. It decreased the IP activity by 28.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are HEALOR LTD, EIGENBRODT ERICH and OPKO RENAL LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 7 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Peptides | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Lee Chee Gun | 11 |
#2 | Oum Ji Hyun | 11 |
#3 | Gui Xiangai | 3 |
#4 | Ajay Vijayakumar | 2 |
#5 | Ji Hyun Oum | 1 |
#6 | Chee Gun Lee | 1 |
Publication | Filing date | Title |
---|---|---|
KR20200072008A | A cell-based method for determining an activity of botulinum toxin | |
KR101983216B1 | Antibodies for determining an activity of botulinum toxin and a method for using the same | |
KR101940500B1 | A cell line for determining botulinum toxin activity and method for using the same | |
KR20190101025A | The stabilized liquid formulations comprising a botulinum toxin, a stabilizer, and a local anesthetic, and a method of producing thereof | |
WO2018038585A1 | Liquid formulation containing botulinum toxin and stabilizing agent, and preparation method therefor |